 |
| Product information |
Product Name: | Tirzepatide |
Synonyms: | Tirzepatide;GIP\GLP-1;Tirzepatide (LY3298176);Trizepatide;Gip\GLP-1 Tirzepatide Ly3298176 Peptide;Tilposide;Tirzepatide(GLP-1);terzapitide |
CAS: | 2023788-19-2 |
MW: | 4813 |
EINECS: | 200-001-8 |
| Tirzepatide – Dual GIP/GLP-1 Agonist for Diabetes and Obesity Treatment |
Tirzepatide (CAS 2023788-19-2) is an innovative peptide drug that acts as a dual GIP and GLP-1 receptor agonist. It has gained global recognition for its proven clinical benefits in Tirzepatide diabetes treatment and its strong efficacy in Tirzepatide weight loss programs. With expanding therapeutic applications, Tirzepatide is becoming a cornerstone molecule in the pharmaceutical pipeline.
| Manufacturing & Quality |
Advanced API Production: As experienced api manufacturers, we employ cutting-edge solid-phase peptide synthesis (SPPS) and advanced purification technologies to ensure high purity and stability.
Regulatory Compliance: Manufactured under strict GMP conditions, our facilities meet global quality standards with comprehensive documentation support (COA, MSDS, DMF).
Reliable Supply: Recognized among the best api manufacturers in China, we provide scalable production capabilities, ensuring consistent supply for both clinical and commercial use.
Trusted Network: We work closely with active pharmaceutical ingredient manufacturers China and global pharmaceutical raw material suppliers to ensure streamlined logistics and cost-effective solutions.
| Applications & Benefits |
Diabetes Care: Widely used in Tirzepatide diabetes treatment, it helps improve insulin sensitivity and glycemic control.
Weight Management: Clinically proven for Tirzepatide weight loss, supporting obesity therapies by reducing body fat.
Appetite & Metabolism: Demonstrates strong efficacy in Tirzepatide appetite suppression & energy intake reduction, addressing the root causes of obesity.
Approved Indications: Expanding therapeutic scope with Tirzepatide approved uses: obesity, T2D, OSA (obstructive sleep apnea), making it a next-generation treatment option.
| Why Partner With Us? |
Expertise in large-scale peptide synthesis and purification
GMP-certified facilities for global regulatory compliance
Flexible CDMO solutions for R&D and commercial projects
Reliable partner for sustainable bulk supply
Tirzepatide is setting new standards in peptide-based therapies for chronic metabolic diseases. With our expertise as a leading API manufacturer, we provide consistent, high-quality supply to support your pharmaceutical development and commercialization needs.
Contact us today for specifications, regulatory support, and bulk supply inquiries.
| Product information |
Product Name: | Tirzepatide |
Synonyms: | Tirzepatide;GIP\GLP-1;Tirzepatide (LY3298176);Trizepatide;Gip\GLP-1 Tirzepatide Ly3298176 Peptide;Tilposide;Tirzepatide(GLP-1);terzapitide |
CAS: | 2023788-19-2 |
MW: | 4813 |
EINECS: | 200-001-8 |
| Tirzepatide – Dual GIP/GLP-1 Agonist for Diabetes and Obesity Treatment |
Tirzepatide (CAS 2023788-19-2) is an innovative peptide drug that acts as a dual GIP and GLP-1 receptor agonist. It has gained global recognition for its proven clinical benefits in Tirzepatide diabetes treatment and its strong efficacy in Tirzepatide weight loss programs. With expanding therapeutic applications, Tirzepatide is becoming a cornerstone molecule in the pharmaceutical pipeline.
| Manufacturing & Quality |
Advanced API Production: As experienced api manufacturers, we employ cutting-edge solid-phase peptide synthesis (SPPS) and advanced purification technologies to ensure high purity and stability.
Regulatory Compliance: Manufactured under strict GMP conditions, our facilities meet global quality standards with comprehensive documentation support (COA, MSDS, DMF).
Reliable Supply: Recognized among the best api manufacturers in China, we provide scalable production capabilities, ensuring consistent supply for both clinical and commercial use.
Trusted Network: We work closely with active pharmaceutical ingredient manufacturers China and global pharmaceutical raw material suppliers to ensure streamlined logistics and cost-effective solutions.
| Applications & Benefits |
Diabetes Care: Widely used in Tirzepatide diabetes treatment, it helps improve insulin sensitivity and glycemic control.
Weight Management: Clinically proven for Tirzepatide weight loss, supporting obesity therapies by reducing body fat.
Appetite & Metabolism: Demonstrates strong efficacy in Tirzepatide appetite suppression & energy intake reduction, addressing the root causes of obesity.
Approved Indications: Expanding therapeutic scope with Tirzepatide approved uses: obesity, T2D, OSA (obstructive sleep apnea), making it a next-generation treatment option.
| Why Partner With Us? |
Expertise in large-scale peptide synthesis and purification
GMP-certified facilities for global regulatory compliance
Flexible CDMO solutions for R&D and commercial projects
Reliable partner for sustainable bulk supply
Tirzepatide is setting new standards in peptide-based therapies for chronic metabolic diseases. With our expertise as a leading API manufacturer, we provide consistent, high-quality supply to support your pharmaceutical development and commercialization needs.
Contact us today for specifications, regulatory support, and bulk supply inquiries.
